Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer - Top-Institutions - MDSpire

Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer

  • By

  • Marcello Migliore

  • Kwon Joong Na

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Thoracic Surgery

  • #2

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Thoracic Surgery

  • #3

    Fujian Cancer Hospital
    Fujian Cancer Hospital

    Fuzhou, Fujian

    Key Differentiators

    • Thoracic Surgery

Original Source(s)

Beyond the platform: why surgical quality and surgeon proficiency outweigh the RATS vs. VATS debate in early-stage lung cancer

  • by Marcello Migliore, Kwon Joong Na

  • July 15, 2026

Related Content

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers

Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab